Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Electroporation Technique May Prevent Restenosis

By HospiMedica International staff writers
Posted on 17 Mar 2009
In a recent study, investigators described the use of a novel tissue ablation method that kills cells by inducing selective damage only to the cell membrane while sparing all other tissue components. More...
This method shows promise for the prevention of restenosis, the reblockage of an artery that had been opened by angioplasty.

The technique, called NTIRE (nonthermal irreversible electroporation), destroys cells within seconds, using very short electric field pulses. The treatment causes no damage to extracellular tissues or structures.

Investigators from the Hebrew University of Jerusalem (Israel) used a group of 33 Sprague-Dawley rats to optimize the NTIRE protocol. Each animal had NTIRE applied to its left common carotid artery using custom-made electrodes that supplied electric pulses of 100 microseconds. The right carotid artery was used as control.

Results published in the March 9, 2009, online edition of the journal PLoS ONE revealed that the most efficient protocols were 10 pulses of 3500 V/cm at a frequency of 10 Hz and 90 pulses of 1750 V/cm at a frequency of 1 Hz, with ablation efficiency of 89 ± 16% and 94 ± 9%, respectively. Extra-cellular structures were not damaged and the endothelial layer recovered completely.

Based on their promising results the authors concluded that, "NTIRE is a promising, efficient and simple novel technology for vascular smooth muscle cell [VMSC] ablation. It enables ablation within seconds without causing damage to extracellular structures, thus preserving the arterial scaffold and enabling endothelial regeneration. This study provides scientific information for future anti-restenosis experiments utilizing NTIRE.”

Related Links:

Hebrew University of Jerusalem



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.